Hai Long

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 8

Top Topics

Hiv Infected Patients

Systematic Review

High Throughput

Top Venues

AIDS research and human retroviruses

Infectious diseases and therapy

Immunity, inflammation and disease

Expert review of anti-infective therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Shujing Ma, Xiaoxin Xie, Yanhua Fu, Lin Gan, Xiaoyan Yang, Linghong Kong, Jun Li, Hai Long
Clinical benefits of novel non-nucleoside reverse transcriptase inhibitors: A prospective cohort study. Immunity, inflammation and disease 12 (4) (2024)
Lei Guo, Yanhua Fu, Xiaoxin Xie, Wan Yan, Hai Long
Comparative Studies on the Efficacy and Safety of Ainuovirine-Based Versus Efavirenz-Based Antiretroviral Therapy in the Management of Persons Living with HIV: A Real-World Study in Guizhou, China. AIDS research and human retroviruses (2024)
Lei Guo, Yanhua Fu, Xiaoxin Xie, Wan Yan, Hai Long
Comparative Studies on the Efficacy and Safety of Ainuovirine-Based Versus Efavirenz-Based Antiretroviral Therapy in the Management of Persons Living with HIV: A Real-World Study in Guizhou, China. AIDS research and human retroviruses 40 (8) (2024)
Lei Guo, Yanhua Fu, Xiaoxin Xie, Wan Yan, Hai Long
Comparative Studies on the Efficacy and Safety of Ainuovirine-Based Versus Efavirenz-Based Antiretroviral Therapy in the Management of Persons Living with HIV: A Real-World Study in Guizhou, China. AIDS research and human retroviruses 40 (8) (2024)
Xiaoxin Xie, Lin Gan, Yanhua Fu, Yebing Song, Chunli Song, Tingting Ren, Chan Ke, Hai Long
Pharmacokinetics and Safety of Ainuovirine/Lamivudine/Tenofovir Combination Tablets in Young and Elderly Patients with Human Immunodeficiency Virus-1 Infection. Infectious diseases and therapy (2023)
Lin Gan, Xiaoxin Xie, Yanhua Fu, Xiaoyan Yang, Shujing Ma, Linghong Kong, Chunli Song, Yebing Song, Tingting Ren, Hai Long
Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir Plus Lamivudine for Switch Therapy in Patients with HIV-1 Infection: A Real-World Cohort Study. Infectious diseases and therapy (2023)
Linghong Kong, Xiaoxin Xie, Yanhua Fu, Lin Gan, Xiaoyan Yang, Shujing Ma, Hai Long
Clinical efficacy, safety, and subjective experience based on ePRO in HIV-infected individuals administered Bictegravir/Emtricitabine/Tenofovir Alafenamide in southwest China. Immunity, inflammation and disease 11 (8) (2023)
Xiaoyan Yang, Yanhua Fu, Xiaoxin Xie, Lin Gan, Chunli Song, Yebing Song, Jun Li, Hai Long
Real-world implementation of dolutegravir plus lamivudine in people living with HIV in Southwest China. Expert review of anti-infective therapy 20 (11) (2022)